PRANA Biotechnology Provides Clinical Trials Safety and Progress Update

Prana Biotechnology today reported on the progress of its lead development asset PBT2 in Phase II trials for Huntington disease and Alzheimer's disease.

http://www.biospace.com/news_story.aspx?StoryID=292292&full=1